Intended research scope
In vitro research, analytical method development, identity verification, and laboratory evaluation only.
Melanocortin Receptor Cyclic Heptapeptide (Bremelanotide)
PT-141 / Bremelanotide — Cyclic Melanocortin Agonist Heptapeptide — Analytical Reference Standard
Select quantity
Multi-Compound Research Program: Orders of 3 or more distinct compound standards qualify for program pricing — program pricing applied at checkout. Diluent does not qualify.
Molecular specifications
Amino acid sequence
View Certificate of Analysis (PDF)
Reference standard description
Analytical-grade reference standard. Cyclic lactam-bridged heptapeptide melanocortin receptor agonist derived from the alpha-MSH pharmacophore. Agonist at MC3R and MC4R. Suitable for melanocortin receptor subtype selectivity assays and CNS peptide pharmacology research. Note: Bremelanotide is an FDA-approved drug (Vyleesi). Supplied as an analytical reference standard for laboratory research purposes only. Certificate of Analysis available online.